Very Brief Blog: Illumina Acquires Edico for $100M

Last year, I had the chance to chair two conference sessions and write an article on the topic of digital genomics, companies dedicated to the digital layer of services rather than running a wetlab at all.

Edico Genome was one of the companies discussed.  This week, it's been acquired by Illumina for $100M.  Over the past several years, Edico had raised $32M in venture capital. 

Edico enables both research and clinical technologies; for example, it's been used by Rady Children's Hospital in landmark applications of rapid genomic sequencing in very ill babies.  (See Farnaes et al., 2018, here.)

• San Diego Union Tribune, here.
• Xconomy, here.
• Genomeweb, here.

Illumina has a market cap of $38B and cash and equivalents of $2B.